-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Amgen, Raises Price Target to $440

Benzinga·11/05/2026 00:31:37
Canaccord Genuity analyst Gary Nachman maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $384 to $440.